Gubra
Kristoffer Rigbolt is currently the CTO at Gubra and also serves as Director of Computational Biology and Principal Scientist in Bioinformatics. Prior to this, Rigbolt worked as a Post Doc at Albert-Ludwigs-Universität Freiburg im Breisgau, focusing on quantitative proteomics and phosphoproteomics. Rigbolt also has experience as a Postdoc and PHD Student at the University of Southern Denmark, working on proteomics and phosphoproteomics related to stem cell differentiation and bioinformatics software development. Rigbolt holds a Master's degree in Biochemistry and Molecular Biology from Syddansk Universitet - University of Southern Denmark.
This person is not in any offices
Gubra
Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.